Linksium

An early stage VC fund focused on investing in Israeli DeepTech and SpaceTech from concept to creation. WHAT DO WE INVEST IN We pursue moonshots driven by breakthrough innovations, seeking companies with core technologies and visionary entrepreneurs dedicated to building impactful, world-changing startups. OPTICS & PHOTONICS QUANTUM TECHNOLOGIES RF TECHNOLOGIES MATERIALS & CHEMISTRY COMPUTER SCIENCE & PROCESSING SEMI-CONDUCTORS ENGINEERING & ELECTRONICS HOW DO WE INVEST We work hand-in-hand with forward-thinking entrepreneurs, as early as the venture building stage, to develop pioneering Deep Tech companies. By utilizing our extensive expertise and resources, we expedite their path to success. WHY DO WE LIKE DEEPTECH The world is changing and growing more complex - the rise of AI, ever increasing climate challenges, the desire to move into an autonomous world, striving to reach the moon and stars - and existing infrastructure is not built to handle this complexity, necessitating a new generation of physical infrastructure which can break the physical barriers of today through cutting edge scientific innovation, enabling the applications of tomorrow.

We use our domain expertise, network, and prior experiences to help our founders scale commercialization, product, and engineering. Post-science project investing We recognize that starting and building a company is hard. Startups by definition are outliers being built by unique collections of humans. We utilize our deep domain expertise to uniquely understand the problems of companies in the categories we care about. Pairing this with our experience working with deep technology, allows us to provide leverage in taking a company from pre, to post-commercialization and building engineering teams across both research and production-level eng.

Unreasonable inventors are combining cutting edge scientific discoveries with the world's biggest challenges to build the next generation of global companies. These are the companies we create and invest in at Main Sequence. We have over $500m under management from lean-in LPs who help our portfolio to prosper. We are investing in the difficult to build companies others struggle to support. Our co-founder is Australia's $1.3b annual budget science agency - CSIRO We invest from seed to Series B, starting our journey as early as possible, driving advantage into our portfolio. Our Advantage Deep tech inventors need more. We have custom built Main Sequence to be ready to help you solve some of the world's greatest challenges with science. We are hands-on and have built a services offering to support founders alongside our capital. Our story Main Sequence was created by CSIRO to address the ‘valley of death’ between research and commercialisation. It solves the world’s greatest challenges by turning our scientific breakthroughs into the next century’s giants. Main Sequence’s origins within CSIRO reflect its commitment to amplifying connections between industry, research and infrastructure to accelerate deep technology development, and reinvesting economic returns from commercialisation back into science. CSIRO Innovation Funds 1 and 2 managed by Main Sequence, have invested in 39 companies since establishment in 2017. These companies have created over 1,200 jobs by working with partners in industry, CSIRO, and 22 Australian universities. The $240 million first CSIRO Innovation Fund , built on a cornerstone investment by government and CSIRO has completed its portfolio and invested in 27 companies since establishment in 2017. The second $300 million CSIRO Innovation Fund commenced investing mid-2021 and had already invested in 12 companies by the end of 2021. Following the Government’s announcement on 1 February 2022 of a reform agenda to accelerate commercialisation of research and collaboration with industry, including $150m support for CSIRO investment in future CSIRO Innovation Funds, Main Sequence welcomes the opportunity to continue to work closely with universities to commercialise Australian research and build Australian companies addressing global challenges. Each of our portfolio companies has some advantage delivered by either one of Australia's 43 universities or an industrial research organisation such as CSIRO. In some cases this exists before we invest, in others we facilitate it as part of the companies pathway to scale and impact.

Oxygea is here to accelerate and invest in people and their business that will drive sustainable innovation and digital transformation. We value ecosystems and we cooperate with local and global networks to provide only the best to startups that will transform the future of the industry. Where do we invest? Circular Economy Technologies intended for reintegrating plastic waste to production chain Extend the useful lifecycle of plastic applications A reduction in the need for production, use, or disposal Carbon Neutrality Energy transition New materials from renewable sources Carbon market CO2 capture, storage and utilization for new chemicals Biotechnology/ Nanotechnology and New Materials New biological and biochemical routes to produce chemicals, plastics and materials Advanced Materials Digital technologies for accelerating R&D developments Plastic as sustainable solution Biopolymers Plastic applications with performance gain Additive manufacturing Smart Factory & Future Mobility Industry 4.0: Analytics, automation and advanced manufacturing technologies Logistics 4.0: Logistics efficiency and improved traceability

Navigare Ventures is an early-stage investor specialized in science-driven companies. Through our investments, we strengthen the industrial and societal impact of research, as well as the long-term financial capacity of our owners, Wallenberg Investments AB. Our core investment themes within deep tech are underpinned by our knowledge and network in a number of scientific fields and industries. These include advanced computing and quantum technologies, synthetic biology and bio innovation, advanced materials and nano technology as well as data-driven life science. We are long term investors - Seed and Series A and beyond - and form deep and lasting partnerships with founders and entrepreneurs. Our extensive industrial and scientific networks gives us the opportunity to provide capital, network, and know-how to transform promising science start-ups into successful companies. Who we are Navigare Ventures, based in Stockholm, is a fully owned subsidiary of Wallenberg Investments AB. We are a team of scientists, industrialists and entrepreneurs who understand the challenges of turning cutting-edge technologies to successful ventures. As part of the Wallenberg ecosystem, our returns fuel the next generation of scientific advancement through research funding from the Wallenberg Foundations to Swedish universities. What we are looking for We partner with experienced entrepreneurial teams that combine scientific excellence with strong business acumen. In this respect, your company should have a unique offering based on a profound understanding of your scientific or technological field and its market and industrial environment. You should also be capable of demonstrating the viability and commercial potential of your product by engaging with real customers. You are raising capital to scale the R&D, production, marketing, and sales capabilities of your company. Our investment philosophy We only invest in companies we understand. While this is an important general principle in any investment activity, it is even more important when making early-stage investments in new technology. If we don’t understand your science, we won’t understand what experts tell us about the value chain and how it works, or what the competitive landscape looks like. And most importantly, we won’t be able to help you develop your strategy and navigate through the challenges of deep-tech start-ups. So, when preparing a meeting with us, don’t put too much emphasis on future revenue projections. That’s important too, in due time. But first, be prepared for long sessions in front of a whiteboard, explaining to us how your material, algorithm, or antibody functions. We don’t need to understand all the equations, but we need to get the heuristics. We are scientists at heart, eager to learn, and we carry a deep conviction that the world is fundamentally understandable. Core investment themesAdvanced computing and quantum technologies: Digitization and automation deepens in industry and society, driven by breakthroughs in computing and AI. Our focus includes improving existing technologies as well as finding completely new platforms in AI and other areas of applied mathematics as well as in novel computer architectures, communication technology, hardware and design. Synthetic biology and bio innovation: Synthetic biology and bio innovations contribute to a more sustainable society. Companies in this field often combine principles of biology, engineering, and computer science for the development of new biological products and manufacturing methods. Advanced materials and nano technology: New materials and nanoscale technology enable disruptions with the potential to benefit numerous existing industries. From quantum materials to biomaterials and biologically inspired nanostructures, we look for the most promising technology platforms in the field. Data-driven life science: Combining digital technology and data with life science drives scientific understanding and enables novel products. Our focus is on data-driven methods to increase personalization and precision of medical interventions, accelerate product development, digitalize care among other advancements.

라플라스파트너스는 초기 단계 기술 기업들의 성장을 돕는 것을 소명으로 여기며, 시장을 확장하는 등 강한 목적의식을 가진 스타트업들과 협력하고 싶습니다. 비전 어떤 문제를 해결하고 세상에 어떤 변화를 가져오고 싶은지, 즉, 미래에 대한 명확한 비전을 그릴 수 있는 팀을 기대합니다. 이유 세상의 많은 문제들 중 왜 ‘그 문제’를 해결하고 싶은지에 대해 납득할 만한 이유가 있는 팀을 선호합니다 가치 ‘비전’과 ‘이유’를 바탕으로 고객에게 얼마나 유의미한 가치를 제공할 수 있는가에 집중합니다. 혁신 기술 라플라스파트너스는 혁신 기술로 문제를 해결하고 새로운 패러다임을 만들어가는 영역에 투자합니다. 바이오·헬스케어 제약, 혁신 진단 기기, 디지털 헬스케어, 건강 기능 식품, 푸드테크 등 소재·부품·장비 2차 전지, 반도체 소재·장비, 에너지, 신소재, 디스플레이, 통신 등 IT 인공지능(AI)의 응용, 전기차, 자율주행, 로봇, 메타버스, 증강현실(AR) 등